Incidence and prevalence rates of inflammatory bowel diseases, in midwester of São Paulo State, Brazil. HRC VICTORIA, C. R., SASSAKI, Ligia Yukie, NUNES Arquivos de Gastroenterologia 46, 20-25, 2009 | 283 | 2009 |
Gut microbiota, inflammatory bowel disease and colorectal cancer AEV Quaglio, TG Grillo, ECS De Oliveira, LC Di Stasi, LY Sassaki World Journal of Gastroenterology 28 (30), 4053, 2022 | 111 | 2022 |
Consensus Guidelines for the Management of Inflammatory Bowel Disease BSGIB Diseases Arquivos de Gastroenterologia 47, 313-325, 2010 | 85* | 2010 |
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised … L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ... The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022 | 79 | 2022 |
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials DT Rubin, I Dotan, A DuVall, Y Bouhnik, G Radford-Smith, PDR Higgins, ... The lancet Gastroenterology & hepatology 7 (1), 17-27, 2022 | 71 | 2022 |
Inflammatory bowel disease epidemiology in São Paulo state, Brazil RG Gasparini, LY Sassaki, R Saad-Hossne Clinical and experimental gastroenterology, 423-429, 2018 | 67 | 2018 |
Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil RS Parra, JMF Chebli, HMBS Amarante, C Flores, JML Parente, O Ramos, ... World Journal of Gastroenterology 25 (38), 5862, 2019 | 65 | 2019 |
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled … BG Feagan, BE Sands, WJ Sandborn, M Germinaro, M Vetter, J Shao, ... The Lancet Gastroenterology & Hepatology 8 (4), 307-320, 2023 | 63 | 2023 |
Body composition in patients with Crohn’s disease and ulcerative colitis IR BACK, SS MARCON, NM GAINO, DSB VULCANO, MS DORNA, ... Arquivos de Gastroenterologia, 109-114, 2017 | 44 | 2017 |
Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis HL de Souza, VR de Carvalho, FG Romeiro, LY Sassaki, R Keller, ... Gut pathogens 4, 1-8, 2012 | 40 | 2012 |
Cardiovascular risk in individuals with inflammatory bowel disease RB Biondi, PS Salmazo, SGZ Bazan, JC Hueb, SAR de Paiva, LY Sassaki Clinical and Experimental Gastroenterology, 107-113, 2020 | 38 | 2020 |
Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes AC da Silva Santos, FG Romeiro, LY Sassaki, J Rodrigues. | 27 | 2015 |
Nutritional intake according to injury extent in ulcerative colitis patients APS Urbano, LY Sassaki, MS Dorna, MA de Barros Leite Carvalhaes, ... Journal of Human Nutrition and Dietetics 26 (5), 445-451, 2013 | 24 | 2013 |
Sexual dysfunction in inflammatory bowel disease: what the specialist should know and ask E Perez de Arce, R Quera, J Ribeiro Barros, L Yukie Sassaki International Journal of General Medicine, 2003-2015, 2021 | 23 | 2021 |
Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study EF de Campos Silva, JP Baima, JR de Barros, SE Tanni, T Schreck, ... Medicine 99 (32), e21686, 2020 | 23 | 2020 |
Acute fatty liver of pregnancy associated with severe acute pancreatitis: A case report CV de Oliveira, A Moreira, JP Baima, L de C Franzoni, TB Lima, ... World journal of hepatology 6 (7), 527, 2014 | 23 | 2014 |
Terapia nutricional nas doenças inflamatórias intestinais: artigo de revisão. LAA SANTOS, MS Dorna, DSB VULCANO, L AUGUSTI, LC FRANZONI, ... Nutrire 40, 386-396, 2015 | 22 | 2015 |
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil C Zaltman, RS Parra, LY Sassaki, GO Santana, MLA Ferrari, ... World Journal of Gastroenterology 27 (2), 208, 2021 | 19 | 2021 |
Analysis of risk factors and postoperative complications in patients with Crohn’s disease RS Hossne, LY Sassaki, JP Baima, JD MEIRA, LM Campos Arquivos de Gastroenterologia 55 (03), 252-257, 2018 | 18 | 2018 |
Incidência e Prevalência de Doenças Inflamatórias Intestinais no Estado de São Paulo-Brasil RG Gasparini Universidade Estadual Paulista (Unesp), 2018 | 17 | 2018 |